METRNL
Meteorin-like protein
Also known as: METRL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q641Q3
- Gene
- METRNL
- Ensembl
- ENSG00000176845
- Chromosome
- 17
- Canonical length
- 311 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Predicted to enable hormone activity. Predicted to be involved in several processes, including brown fat cell differentiation; positive regulation of brown fat cell differentiation; and response to muscle activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>Q641Q3|METRNL
1 MRGAARAAWG RAGQPWPRPP APGPPPPPLP LLLLLLAGLL GGAGAQYSSD RCSWKGSGLT
61 HEAHRKEVEQ VYLRCAAGAV EWMYPTGALI VNLRPNTFSP ARHLTVCIRS FTDSSGANIY
121 LEKTGELRLL VPDGDGRPGR VQCFGLEQGG LFVEATPQQD IGRRTTGFQY ELVRRHRASD
181 LHELSAPCRP CSDTEVLLAV CTSDFAVRGS IQQVTHEPER QDSAIHLRVS RLYRQKSRVF
241 EPVPEGDGHW QGRVRTLLEC GVRPGHGDFL FTGHMHFGEA RLGCAPRFKD FQRMYRDAQE
301 RGLNPCEVGT DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against METRNL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 248 nTPM
Expression across tissuesHPA
Tissue
- skin: 248 nTPM
- esophagus: 185 nTPM
- blood vessel: 113 nTPM
- adipose tissue: 103 nTPM
- vagina: 102 nTPM
- cervix: 95 nTPM
Single-cell type
- nk-cells: 29 nCPM
- bergmann glia: 27 nCPM
- renal connecting tubule cells: 23 nCPM
- renal collecting duct intercalated cells: 22 nCPM
- renal collecting duct principal cells: 22 nCPM
- choroid plexus epithelial cells: 16 nCPM
Immune cell
- eosinophil: 11 nTPM
- non-classical monocyte: 8.2 nTPM
- basophil: 6.8 nTPM
- intermediate monocyte: 6 nTPM
- neutrophil: 5.5 nTPM
- myeloid DC: 4.5 nTPM
Brain region
- choroid plexus: 67 nTPM
- thalamus: 30 nTPM
- midbrain: 18 nTPM
- medulla oblongata: 17 nTPM
- cerebral cortex: 15 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.75
- gnomAD missense Z
- 1.11
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brown fat cell differentiation
- energy homeostasis
- fat cell differentiation
- negative regulation of inflammatory response
- positive regulation of brown fat cell differentiation
- response to cold
- response to muscle activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads METRNL as an antibody target. Whether an autoantibody or antibody against METRNL could matter depends on whether native METRNL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
METRNL is annotated as secreted, so native METRNL circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label METRNL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...